Quarterly report · Q1
3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥43.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥999m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥104.0bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥98.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥54.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥49.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥44.5bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥27.22 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.18 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥876m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥39.6bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥39.5bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥86m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥327m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥43.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥43.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥102m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥830m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥17m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥3.5bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥60m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥349m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥40.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥40.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥77m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember | 86000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 102000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -102000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 39563000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember | 3942000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 43506000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -102000000 | JPY |
| Net sales | CurrentYTDDuration | 43403000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 2422000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember | 327000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 2749000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -876000000 | JPY |
| Operating income | CurrentYTDDuration | 1873000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第32期第１四半期 (自 2023年４月１日 至 2023年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)クオールホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Qol Holdings Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 中村 敬 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03－6430－9060 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営管理部 部長 緒方 伸一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03－6430－9060 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理部 部長 緒方 伸一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03476 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 30340 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)クオールホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Qol Holdings Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |